Superior vena cava syndrome after subclavian vein chemotherapy port replacement in a patient with breast cancer.
Ozcinar
Beyza
B
General Surgery Department, Istanbul University, Istanbul, Turkey. beyzazcinan@yahoo.com
Ozmen
Vahit
V
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002408:Catheters, Indwelling / Q000009:adverse effects*; D020878:Device Removal; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015409:Mastectomy, Radical; D013350:Subclavian Vein; D013479:Superior Vena Cava Syndrome / Q000209:etiology* / Q000473:pathology* / Q000628:therapy
D000925:Anticoagulants; D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight